CEPI to fund Gennova's self­ amplifying mRNA vaccine against Disease X

The Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop vaccine candidates against unknown pathogenic threats with the particular development of saRNA vaccines that use the body's own machinery to make antigenic protein.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HxyYthg
via IFTTT